Flt3-itd measurable residual disease monitoring in acute myeloid leukemia using next-generation sequencing

HIGHLIGHTS

• who: Jong-Mi Lee and colleagues from the Department of Laboratory Medicine, Seoul StMary`s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea have published the research work: FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing, in the Journal: Cancers 2022, 14, 6121. of /2022/
• what: The authors developed a novel assay using the SEED sequence to analyze the FLT3-ITD MRD using the NGS data.
• how: The MRD status at remission combined with the clinical data was examined for the prognostic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.